Sangamo Therapeutics, Inc.【SGMO】 業績推移・財務諸表

(単位:千ドル) 2011/12 2012/12 2013/12 2014/12 2015/12 2016/12 2017/12 2018/12 2019/12 2020/12 2021/12 2022/12 2023/12 2024/12
売上高 10,319 21,655 24,133 45,870 39,539 19,389 36,567 84,452 102,428 118,192 110,701 111,299 176,232 57,800
売上成長率(%) - 15.39 -6.34 0.54 58.34 -67.2
研究開発費 32,098 31,709 36,979 56,744 67,198 65,618 65,728 114,866 145,922 180,647 230,819 249,898 234,057 111,521
営業費用 46,140 43,853 50,839 72,651 86,395 91,948 92,928 161,602 207,608 247,744 294,038 312,580 450,237 161,769
営業利益 -35,821 -22,198 -26,706 -26,781 -46,856 -72,559 -56,361 -77,150 -105,180 -129,552 -183,337 -201,281 -274,005 -103,969
営業利益率 (%) -109.61 -165.61 -180.85 -155.48 -179.88
経常(税引前)利益 - - - - -46,425 -71,672 -54,568 -68,889 -95,419 -120,777 -177,991 -191,849 -262,903 -98,108
経常(税引前)利益率(%) - - - - -117.42 -369.65 -149.23 -81.57 -93.16 -102.19 -160.79 -172.37 -149.18 -169.74
法人税等合計 - - - - -5,722 -14 - - - 345 306 429 -5,072 -167
実効税率(%) - - - - - - - 0 0 0 0 0
純利益 -35,750 -22,264 -26,624 -26,417 -40,703 -71,658 -54,568 -68,334 -95,186 -120,996 -178,286 -192,278 -257,831 -97,941
純利益率(%) -102.37 -161.05 -172.76 -146.3 -169.45
一株あたり利益 - - - - - - - - - - -1.23 -1.25 -1.48 -0.49
希薄化後一株あたり利益 - - - - - - - - - - -1.23 -1.25 -1.48 -0.49
EBITDA -123,852 -173,937 -189,181 -258,905 -98,869
EBITDAマージン(%) -104.79 -157.12 -169.98 -146.91 -171.05